Ophthalmic Devices Market size is expected to be worth around USD 80.4 Bn by 2033 from USD 50.3 Bn in 2023, growing at a CAGR of 4.8%.

The United Kingdom Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

Snapshot img

Ophthalmology Devices Market Size 2024-2028

The ophthalmology devices market size is forecast to increase by USD 19.1 billion at a CAGR of 4.31% between 2023 and 2028.

The market is witnessing significant growth due to several key trends. The increasing prevalence of ophthalmic diseases is a major driver for market growth. According to the World Health Organization, approximately 217 million people worldwide are affected by blindness or low vision. Moreover, the rising number of medical tourism cases for affordable ophthalmology surgeries in developing countries is also boosting the market growth. Advancements in technology have led to the development of cutting-edge devices such as artificial intelligence (AI) in ophthalmology, fundus cameras, OCT scanners, and phacoemulsification machines. However, high costs and limited reimbursement for ophthalmic treatments pose a challenge to market growth. Despite these challenges, the market is expected to witness steady growth due to the development of advanced technologies and increasing government initiatives to improve healthcare infrastructure. The market trends and analysis report provides a comprehensive overview of these factors and more, offering valuable insights for stakeholders in the ophthalmology devices industry.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market encompasses a broad range of innovative technologies designed to address various optical disorders and surgical needs. This market includes devices for refractive surgery, such as LASIK and photorefractive keratectomy (PRK), which correct vision impairments caused by refractive defects. Additionally, retinal surgery devices are essential for treating conditions like diabetic retinopathy, vitreoretinal disorders, and glaucoma. Phacoemulsification devices and premium intraocular lenses (IOLs) are integral components of cataract operations. Phacoemulsification is a minimally invasive procedure that uses ultrasonic energy to fragment and remove cataract-affected lenses, while premium IOLs offer improved visual acuity and functionality. UV screens and refurbished equipment play a crucial role in the ophthalmic medical device market, ensuring the protection of the eyes from harmful radiation and extending the life cycle of surgical instruments.



Ophthalmic surgical instruments and diagnostic instruments cater to the needs of various ophthalmic procedures, from cataract operations to strabismus correction. The geriatric population represents a significant portion of the market, as age-related conditions like cataracts, glaucoma, and diabetic retinopathy are common among older adults. Binocular vision disorders and refractive defects are also prevalent, necessitating the continuous development and refinement of ophthalmic medical devices. Lasers and phacoemulsification machines are essential tools in the ophthalmic medical device market, enabling precise and efficient surgical procedures. The ongoing advancements in technology lead to improved patient outcomes and expanded treatment options. In summary, the ophthalmic medical device market is a dynamic and evolving sector, driven by the need to address various optical disorders and surgical requirements. The development and refinement of technologies, such as phacoemulsification devices, premium IOLs, lasers, and surgical instruments, are essential in meeting the demands of healthcare professionals and patients alike.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Vision care
  Ophthalmology surgical devices
  Ophthalmology diagnostic devices


End-user

  Hospitals and eye clinics
  Academic and research laboratories
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By Product Insights

The vision care segment is estimated to grow significantly during the forecast period.

The market encompasses a range of products used in the diagnosis, treatment, and management of various eye conditions. These devices include diagnostic instruments, such as slit lamps, fundus cameras, and optical coherence tomography (OCT) machines, which aid in the detection and monitoring of diseases like CMV retinitis, diabetic retinopathy, and diabetic macular edema.

Additionally, the market includes corrective eyewear, such as contact lenses and spectacle lenses, with the latter being the most commonly used form of eyewear for correcting refractive errors. Plastic spectacle lenses, in particular, have gained popularity due to their advantages, including lightweight, break resistance, and su

According to Cognitive Market Research, the global ophthalmology devices market size is USD 7.0 million in 2024 and will expand at a compound annual growth rate (CAGR) of 4.92% from 2024 to 2031. Market Dynamics of Ophthalmology Devices Market

Key Drivers for Ophthalmology Devices Market

Rise is Cases for Ophthalmic Diseases - Ophthalmic illnesses, including glaucoma and cataracts, are becoming more common, which is a major driver fueling the expansion of the ophthalmology devices market. With the growing need for contact lenses and cutting-edge equipment, these devices are poised to dominate the industry. The market for microinvasive glaucoma surgical implants is expanding at a faster rate than any other treatment. Common eye problems like diabetic retinopathy, cataracts, age-related macular degeneration, and all the other ophthalmic illnesses are expected to fuel market expansion. Rising consumer awareness of ophthalmology devices and an uptick in research and development efforts to create new ones are anticipated to drive the market's expansion.

Key Restraints for Ophthalmology Devices Market

The absence of knowledge on eye-related illnesses is expected to slow down the market's growth. A lack of qualified individuals is expected to pose a problem for the ophthalmology equipment industry. Introduction of the Ophthalmology Devices Market

Ophthalmic devices are medical tools commonly used for diagnosing eye conditions, correcting visual problems, and performing surgeries. Their advantages are becoming more well-known and popular due to the increasing number of people suffering from ophthalmic ailments like glaucoma, cataracts, and others that affect eyesight. The global ophthalmic devices market is expected to experience expansion due to the rising demand for high-quality eye care and the increasing number of procedures meant to correct visual problems. The developing world's improving healthcare infrastructure, along with the rising demand for and demand for less-invasive processes, is anticipated to enhance the expansion of the market.

The ophthalmic diagnostic equipment market is expected to grow from USD 3.56 billion in 2025 to USD 5.02 billion by 2035. The market is poised to expand at a 3.5% CAGR during the forecast period.

Ophthalmic Diagnostic Equipment Market Analyzed by Top Investment Segments

Analyzing Top Countries Producing and Distributing Ophthalmic Diagnostic Equipment

Global Ophthalmic Devices market size is expected to reach $70.64 billion by 2029 at 8.1%, the impact of increasing incidence and prevalence of eye diseases on the ophthalmic devices market

The global ophthalmic devices market size reached USD 28.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 39.7 Billion by 2033, exhibiting a growth rate (CAGR) of 3.52% during 2025-2033. The market is propelled by the expanding geriatric population, rising prevalence of eye ailments, and the growing medical tourism sector which is driving innovation and investment in advanced eye care technologies.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on product type, application, and end use.

Ophthalmic Devices Market is projected to reach 83.33 billion by 2033, growing at a CAGR of 6.5% from 2025-2033.

The United States Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

The India Ophthalmology Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More. The Market Forecasts are Provided in Terms of Value (USD).

The size of the India Ophthalmology Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 7.30% during the forecast period. Indian Ophthalmology Devices Market: Among the rapidly growing products in the health industry, the market for ophthalmology devices is growing due to soaring disposable incomes and increasing eye diseases, coupled with rising awareness levels for eye care. Medical instruments and technologies used for diagnosis, treatment, and management of various eye conditions come under the umbrella of ophthalmology devices. These devices include intraocular lenses (IOLs), diagnostic equipment that spans from OCT, to fundus cameras and visual field analyzers, surgical instruments that consist of phacoemulsifiers and laser systems, contact lenses, and ophthalmic drugs. These include a wide variety of diseases that are addressed by ophthalmology, devices that include cataracts, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and refractive errors. For example, IOLs are implanted in cataract surgeries to replace the cloudy lens and restore one's vision. Diagnostic equipment helps to make early diagnoses and monitor the diseases of the eye so that appropriate measures are taken in time. Operations are carried out with surgical instruments, which have made operations practically painless with minimal invasion, preventing a longer recovery time and improved patient outcome. Contact lenses correct what is commonly termed as refractory errors: myopia, hypermetropia, and astigmatism. Ophthalmic drugs treat conditions such as dry eye syndrome and infections where the eyes are uncomfortable and unhealthy, or glaucoma. Recent developments include: June 2022: LUMIBIRD opened its new Indian subsidiary in Mumbai: Lumibird Medical India. This company aims to boost the sales of Quantel Medical and Ellex products in India which has a vast range of ultrasound platforms, ophthalmic lasers and equipment for the diagnosis and treatment of dry eye disease., January 2022: Alcon launched the presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology, the AcrySof IQ Vivity IOL (Vivity), in India.. Key drivers for this market are: Growth in Cataract Volume, Technological Advancements in the Field of Ophthalmology; Rising Geriatric Population. Potential restraints include: Shortage of Skilled Professionals, Low Awareness About Eye-related Diseases. Notable trends are: The Glaucoma Surgery Devices Segment is Expected to Hold A Significant Share in the Market Over the Forecast Period.

Global ophthalmic equipment market size was valued at USD 61.1 billion in 2021 and is expected to grow at a CAGR of 4.8% during the forecast period.

The Spain Ophthalmic Devices Market Report is Segmented by Device Type (Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care Devices), Disease Indication (Cataract, Glaucoma, Diabetic Retinopathy, Other Disease Indications), End-User (Hospitals, Specialty Ophthalmic Clinics, and More). The Market Forecasts are Provided in Terms of Value (USD).

Snapshot img

Ophthalmology Surgical Devices Market Size 2024-2028

The ophthalmology surgical devices market size is forecast to increase by USD 2.81 billion at a CAGR of 5.21% between 2023 and 2028.

The market is witnessing significant growth due to the increasing prevalence of ophthalmic diseases. According to the National Eye Institute, around 285 million people worldwide are estimated to be visually impaired, with 80% of cases attributable to preventable causes. This trend is driving the demand for advanced surgical devices to address various eye conditions. Strategic collaborations and mergers and acquisitions among market companies are also contributing to market growth. However, high costs and limited reimbursements pose challenges to the market expansion. Despite these hurdles, the market is expected to continue its upward trajectory due to the unmet medical needs and technological advancements In the field of ophthalmology.

What will be the Size of the Ophthalmology Surgical Devices Market During the Forecast Period?

Request Free SampleThe market encompasses a range of advanced technologies designed to address various eye disorders, including cataracts, glaucoma, and diabetic retinopathy. Key market drivers include the growing prevalence of ophthalmic disorders, particularly among the geriatric population, and the increasing demand for minimally invasive surgical procedures. Cataract surgeries, which involve the implantation of intraocular lenses, remain a significant segment of the market due to the high incidence of advanced cataracts and the resulting symptoms such as blurred vision, glare, and visual changes. Microscopes and robotic technologies are also gaining traction, enabling more precise and efficient ophthalmic surgeries. The backlog of patients seeking consultations for ocular disorders continues to fuel market growth.Symptoms like eye redness, refractive errors, and symptoms related to diabetes and other conditions further expand the market scope. Laser surgery and the development of advanced artificial lenses continue to shape the market landscape.

How is this Ophthalmology Surgical Devices Industry segmented and which is the largest segment?

The ophthalmology surgical devices industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments. ProductCataract surgery devicesGlaucoma surgery devicesRefractive surgery devicesVitreoretinal surgery devicesGeographyNorth AmericaUSEuropeGermanyUKAsiaChinaJapanRest of World (ROW)

By Product Insights

The cataract surgery devices segment is estimated to witness significant growth during the forecast period.

Ophthalmology surgical devices play a crucial role in addressing various eye disorders, including cataracts and glaucoma. Cataracts, a leading cause of vision impairment, affect individuals due to aging or eye injuries, and are associated with symptoms such as blurred vision, difficulty reading, and visual changes. According to the National Eye Institute, over 24.4 million Americans aged 40 and above have cataracts. Glaucoma, another prevalent ophthalmic disorder, affects over 3 million Americans and results in severe visual impairment or blindness if left untreated. Advanced technologies like microscopes, robotic technologies, and laser technology are transforming ophthalmic surgeries, including cataract surgeries utilizing phacoemulsification systems and intraocular lenses.Technological advancements, such as SmartCataract solutions and the Hydrus Microstent for glaucoma, offer innovative alternatives for managing ophthalmic disorders. The geriatric population, with its increasing prevalence of cataracts and glaucoma, drives the demand for these surgical devices. The ophthalmic equipment market encompasses a wide range of surgical products, including vitreoretinal surgery devices, ophthalmology drugs, and glaucoma surgical devices. The aging population and the increasing prevalence of eye disorders, such as cataract, diabetic retinopathy, and macular degeneration, necessitate advancements in ophthalmic equipment.

Get a glance at the Ophthalmology Surgical Devices Industry report of share of various segments Request Free Sample

The Cataract surgery devices segment was valued at USD 3.4 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 43% to the growth of the global market during the forecast period.

Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American the market is experiencing significant growth due to increasing healt

The Ophthalmic Surgical Devices Market Report is Segmented by Product (Refractive Surgery Devices, Glaucoma Surgery Devices, Cataract Surgery Devices, and Other Surgical Devices), End-User (Hospitals, Specialty Ophthalmic Clinics, Ambulatory Surgery Centers (ASCs), and Other End-Users), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

The size of the Ophthalmology Devices Market was valued at USD 81.31 billion in 2024 and is projected to reach USD 109.25 billion by 2033, with an expected CAGR of 4.31% during the forecast period. The ophthalmology devices market is growing rapidly due to the increasing global prevalence of eye diseases and vision impairment. These devices are used in the diagnosis, treatment, and management of various eye conditions such as cataracts, glaucoma, diabetic retinopathy, macular degeneration, and refractive errors. An aging population, rising rates of diabetes and hypertension (which contribute to eye diseases), and increased awareness about the importance of eye care are driving the market. Technological advancements in ophthalmology devices are playing a major role in market growth. Innovations such as laser-based systems, minimally invasive surgical devices, and diagnostic tools that provide real-time imaging are improving patient outcomes and reducing recovery times. Moreover, the increasing adoption of advanced diagnostic tools like optical coherence tomography (OCT), fundus cameras, and visual field analyzers is enhancing the precision of eye care. The market is also expanding through the demand for refractive surgery devices, including LASIK systems, due to the increasing number of people seeking refractive corrections other than corrective eyewear. Besides, wearable devices and mobile health technologies in eye care are expanding the market, enabling patients to handle certain aspects of eye health at home.

Global Ophthalmology Devices market size earned around $40.38 Bn in 2023 and is expected to reach $65.49 Bn by 2032, with a projected CAGR of 5.52%.

Ophthalmology Devices Market Outlook

The global ophthalmology devices market size was valued at approximately USD 56 billion in 2023 and is projected to reach about USD 95 billion by 2032, exhibiting a compound annual growth rate (CAGR) of around 6.2% during the forecast period. The rapid growth of this market can be attributed to the increasing prevalence of ocular diseases, technological advancements in ophthalmic devices, and a growing aging population worldwide. Factors such as rising incidences of age-related macular degeneration, diabetic retinopathy, cataracts, and glaucoma are pushing the demand for advanced diagnostic and surgical solutions, thereby propelling the market growth of ophthalmology devices.

The aging global population is one of the primary drivers of the ophthalmology devices market. As life expectancy increases, the prevalence of age-related eye disorders such as cataracts and glaucoma also rises, creating a substantial demand for both diagnostic and surgical ophthalmic devices. Moreover, changing lifestyle habits, such as increased screen time and exposure to digital screens, have led to a surge in vision-related issues among younger populations, further boosting the demand for ophthalmology solutions. The surge in demand is accelerated by increased healthcare expenditure, innovations in healthcare infrastructure, and the growing awareness regarding eye health which is encouraging regular eye check-ups.

Technological advancements in ophthalmology devices stand as another significant growth factor for the market. The integration of artificial intelligence, machine learning, and robotic systems into ophthalmic devices is revolutionizing the industry by enhancing the accuracy, safety, and efficiency of ophthalmic procedures. Innovations such as femtosecond laser-assisted cataract surgery, advanced intraocular lenses, and minimally invasive surgical techniques are gaining traction, providing faster recovery times and better visual outcomes for patients. These technological strides not only improve patient outcomes but also expand the capabilities of ophthalmology professionals, fueling market expansion.

The robust emergence of teleophthalmology is another key growth factor, especially in remote and underserved regions. With the increasing adoption of digital health platforms, teleophthalmology provides a vital solution for patients who have limited access to in-person eye care services. This trend has been further accelerated by the COVID-19 pandemic, which necessitated the adoption of remote healthcare services globally. Teleophthalmology not only offers convenience but also ensures early detection and treatment of eye disorders, thereby contributing significantly to market growth.

Regionally, the ophthalmology devices market presents diverse dynamics. North America holds a dominant position due to its well-established healthcare infrastructure, high prevalence of eye disorders, and substantial investment in research and development. Meanwhile, the Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by the burgeoning healthcare sector, rapidly aging population, and increasing awareness of eye health. Additionally, favorable government initiatives in emerging markets like India and China are set to boost the adoption of advanced ophthalmology devices. The European market, characterized by high healthcare expenditure and a strong focus on innovation, also remains a significant contributor to the global ophthalmology devices market.

Product Type Analysis

The ophthalmology devices market is broadly segmented into diagnostic and monitoring devices, surgical devices, and vision care devices. Diagnostic and monitoring devices encompass a range of equipment used to assess and diagnose eye conditions, including optical coherence tomography (OCT) machines, fundus cameras, and tonometers. These devices have seen significant growth due to escalating demand for early diagnosis and proactive management of ocular diseases. The continuous evolution in diagnostic technology, such as the incorporation of artificial intelligence for enhanced image recognition and interpretation, is expected to further drive market growth. Additionally, the increasing trend of personalized medicine is fostering innovation in diagnostic tools that allow for tailored treatment plans.

Surgical devices form a crucial segment within the ophthalmology devices market, comprising equipment used for various eye surgeries, such as phacoemulsification systems for cataract surgeries, vitrectomy machines for vitreoretinal procedures, and laser syst

The size of the China Ophthalmic Devices Market was valued at USD XX Million in 2023 and is projected to reach USD XXX Million by 2032, with an expected CAGR of 4.50% during the forecast period. The Chinese ophthalmic devices market is a growing sector that is primarily driven by the increasing awareness of eye health, increasing population age, and rising technological inputs. Ophthalmic devices are the medical instruments or equipment used in diagnosing, treating, and managing many eye conditions. These devices include a broad range of products, such as intraocular lenses (IOLs), contact lenses, surgical instruments, diagnostic equipment, and laser systems. IOLs are actually implanted during cataract surgery so that the cloudy lens is replaced by a clear artificial one to regain vision. Contact lenses can correct refractive errors including myopia, hypermetropia, and astigmatism, presenting an option other than eyeglasses. Surgical instruments are necessary for performing surgeries in the eyes like cataract removal, treatment of glaucoma, and repair of retinal detachment. Diagnostic tools comprise an ophthalmoscope, a tonometer, and visual acuity chart to evaluate the general health of the eye as well as any anomalies. The laser systems are involved in many types of eye surgery- laser eye correction, glaucoma treatment and retinal surgery. The Chinese ophthalmic devices market is experiencing tremendous growth due to several reasons. The need for preventive care and treatment has become much more aware of, thus boosting the demand for products related to eye health. The population aged 60 years or above, which usually faces an increased risk of suffering from diseases such as cataract and glaucoma, is another reason for expansion in the market. Additionally, technological advances also influence the invention of better and efficient ophthalmic appliances, thus powering higher growth in the market. Recent developments include: June 2022: Samsara Vision teamed up with Lansheng Medical "MyVision," a China-based ophthalmology company, to create a comprehensive clinical and commercial organization to support Samsara Vision's SING IMTTM (Smaller-Incision New-Generation Implantable Miniature Telescope) in mainland China, Macau, the Hainan Province, and Hong Kong., June 2022: The National Medical Products Administration in China granted Iridex Corporation permission to market and sell its Cyclo G6 platform for the treatment of glaucoma illnesses (NMPA). According to the clearance, Iridex and distribution partners Topcon and Clinico will begin selling the Cyclo G6 system and accompanying probes in China in the third quarter of 2022.. Key drivers for this market are: Increasing Prevalence of Eye Diseases, Technological Advancements in Ophthalmic Devices. Potential restraints include: Risk Associated with Ophthalmic Procedures. Notable trends are: Glaucoma Devices Segment is Expected to Show Better Growth over the Forecast Period.

The global ophthalmology devices market, valued at $41.85 billion in 2025, is projected to experience steady growth, driven by several key factors. The aging global population, leading to an increased prevalence of age-related eye diseases like cataracts, glaucoma, and macular degeneration, significantly fuels market expansion. Technological advancements in surgical procedures like minimally invasive cataract surgery and refractive procedures like LASIK are also contributing to market growth, along with the rising adoption of advanced diagnostic imaging technologies for early disease detection and improved treatment outcomes. Furthermore, increased healthcare expenditure and improved access to healthcare in developing economies are expanding market reach. However, high costs associated with advanced devices and procedures, coupled with stringent regulatory approvals, pose challenges to market growth. The competitive landscape is dominated by established players like Alcon, Bausch + Lomb, and Johnson & Johnson, who continually invest in research and development to maintain their market positions. Smaller, specialized companies are also contributing significantly through innovation in niche areas. The market's segmentation, while not provided, is likely categorized by device type (e.g., intraocular lenses, diagnostic devices, surgical instruments), treatment area (e.g., cataracts, glaucoma, refractive errors), and end-user (e.g., hospitals, ophthalmologist clinics). Future growth will likely be influenced by the ongoing development of personalized medicine approaches in ophthalmology, artificial intelligence-driven diagnostic tools, and the increasing availability of teleophthalmology services. Based on the provided CAGR of 2.8% and a 2025 market size of $41.85 billion, we can project continued, albeit moderate, expansion. This growth is expected to be consistent across various segments and geographic regions, although the rate might vary slightly. The market's steady expansion is underpinned by the consistent increase in the prevalence of age-related eye diseases, alongside the ongoing innovation within the sector. While potential economic downturns could impact market growth, the high unmet needs in ophthalmic care and the vital nature of these procedures ensure the long-term resilience of the market. This suggests sustained investment opportunities in the sector, primarily within research and development, market expansion into emerging economies, and consolidation within the existing player landscape.